α- and β-Globin Gene Mutations in Individuals with Hemoglobinopathies in the Chattogram and Sylhet Regions of Bangladesh

References

• Chung EH, Bhagavan BV, editors. Hemoglobin. Essentials of medical biochemistry [Internet]. 2nd ed. Burlington (MA): Elsevier; 2011. p. 355–368.
   Google Scholar
• Dasgupta A, Wahed A, editors. Hemoglobinopathy. Clinical chemistry, immunology and laboratory quality control [Internet]. 1st ed. San Diego (CA): Elsevier; 2014. p. 363–390.
   Google Scholar
• Kohne E. Hemoglobinopathies: clinical manifestations, diagnosis, and treatment. Dtsch Arztebl Int. 2011;108(31-32):532–540.
   PubMed Web of Science ®Google Scholar
• Eaton WA, Bunn HF. Treating sickle cell disease by targeting HbS polymerization. Blood. 2017;129(20):2719–2726.
   PubMed Web of Science ®Google Scholar
• Silberstein P. Thalassemia. In: Enna SJ, Bylund DB, editors. xPharm: the comprehensive pharmacology reference [Internet]. Amsterdam (Netherlands): Elsevier; 2008. p. 1–6.
   Google Scholar
• Cohen AR, Galanello R, Pennell DJ, et al. Thalassemia. Hematology Am Soc Hematol Educ Program. 2004;2004(1):14–34.
   Google Scholar
• Higgs DR. The molecular basis of α-thalassemia. Cold Spring Harb Perspect Med. 2013;3(1):a011718.
   PubMed Web of Science ®Google Scholar
• Farashi S, Harteveld C. Molecular basis of α-thalassemia. Blood Cells Mol Dis. 2018;70:43–53.
   PubMed Web of Science ®Google Scholar
• Lie-Injo LE, Lie HG, Ager JA, et al. α-Thalassaemia as a cause of hydrops foetalis. Br J Haematol. 1962;8(1):1–4.
   Web of Science ®Google Scholar
• Chui DHK. α-thalassemia: Hb H disease and Hb Barts hydrops fetalis. Ann N Y Acad Sci. 2005;1054(1):25–32.
   Web of Science ®Google Scholar
• Rund D, Rachmilewitz E. β-thalassemia. N Engl J Med. 2005;353(11):1135–1146.
   PubMed Web of Science ®Google Scholar
• Winichagoon P, Fucharoen S, Thonglairoam V, et al. β-thalassemia in Thailand. Ann N Y Acad Sci. 1990;612(1):31–42.
   Web of Science ®Google Scholar
• Patrinos GP, Giardine B, Riemer C, et al. Improvements in the HbVar database of human hemoglobin variants and thalassemia mutations for populations and sequence variation studies. Nucleic Acids Res. 2004;32(Database issue):D537–D541.
   PubMed Web of Science ®Google Scholar
• Noor FA, Sultana N, Bhuyan GS, et al. Nationwide carrier detection and molecular characterization of β-thalassemia and hemoglobin e variants in Bangladeshi population. Orphanet J Rare Dis. 2020;15(1):15.
   PubMed Web of Science ®Google Scholar
• Anwar S, Taslem Mourosi J, Hasan MK, et al. Umbilical cord blood screening for the detection of common deletional mutations of α-thalassemia in Bangladesh. Hemoglobin. 2020;44(3):201–210.
   PubMed Web of Science ®Google Scholar
• Hosen MJ, Anwar S, Taslem Mourosi J, et al. Genetic counseling in the context of Bangladesh: current scenario, challenges, and a framework for genetic service implementation. Orphanet J Rare Dis. 2021;16(1):168.
   PubMed Web of Science ®Google Scholar
• Hossain MS, Raheem E, Sultana TA, et al. Thalassemias in South Asia: clinical lessons learnt from Bangladesh. Orphanet J Rare Dis. 2017;12(1):93.
   PubMed Web of Science ®Google Scholar
• Hassan S, Ahmad R, Zakaria Z, et al. Detection of β-globin gene mutations among β-thalassaemia carriers and patients in Malaysia: application of multiplex amplification refractory mutation system-polymerase chain reaction. Malays J Med Sci. 2013;20(1):13–20.
   PubMedGoogle Scholar
• Bhardwaj U, Zhang Y-H, Lorey F, et al. Molecular genetic confirmatory testing from newborn screening samples for the common African-American, Asian Indian, Southeast Asian, and Chinese β-thalassemia mutations. Am J Hematol. 2005;78(4):249–255.
   PubMed Web of Science ®Google Scholar
• Rahman SA, Rahaman MSE, Shipa SA, et al. Detection of β-hemoglobin gene and sickle cell disorder from umbilical cord blood. J Biosci Med. 2017;5(10):51–63.
   Google Scholar
• Chan YF, Tan KL, Wong YC, et al. The use of the amplification refractory mutation system (arms) in the detection of rare β-thalassemia mutations in the Malays and Chinese in Malaysia. Southeast Asian J Trop Med Public Health. 2001;32(4):872–879.
   PubMedGoogle Scholar
• Varawalla NY, Old JM, Sarkar R, et al. The spectrum of β-thalassaemia mutations on the Indian subcontinent: the basis for prenatal diagnosis. Br J Haematol. 1991;78(2):242–247.
   PubMed Web of Science ®Google Scholar
• Old JM. Screening and genetic diagnosis of haemoglobin disorders. Blood Rev. 2003;17(1):43–53.
   PubMed Web of Science ®Google Scholar
• Old JM, Varawalla NY, Weatherall DJ. Rapid detection and prenatal diagnosis of β-thalassaemia: studies in Indian and Cypriot populations in the UK. Lancet. 1990;336(8719):834–837.
   PubMed Web of Science ®Google Scholar
• Waterfall CM, Cobb BD. Single tube genotyping of sickle cell anaemia using PCR-based SNP analysis. Nucleic Acids Res. 2001;29(23):E119.
   PubMed Web of Science ®Google Scholar
• Angelucci E, Matthes-Martin S, Baronciani D, et al. Hematopoietic stem cell transplantation in thalassemia major and sickle cell disease: indications and management recommendations from an international expert panel. Haematologica. 2014;99(5):811–820.
   PubMed Web of Science ®Google Scholar
• Hehre RJ. Managing patients with sickle cell disease in primary care. JAAPA. 2020;33(10):21–28.
   PubMedGoogle Scholar
• Cappellini MD. Exjade(R) (deferasirox, ICL670) in the treatment of chronic iron overload associated with blood transfusion. Ther Clin Risk Manag. 2007;3(2):291–299.
   PubMedGoogle Scholar
• Taher AT, Porter J, Viprakasit V, et al. Deferasirox reduces iron overload significantly in nontransfusion-dependent thalassemia: 1-year results from a prospective, randomized, double-blind, placebo-controlled study. Blood. 2012;120(5):970–977.
   PubMed Web of Science ®Google Scholar
• Gardenghi S, Marongiu MF, Ramos P, et al. Ineffective erythropoiesis in β-thalassemia is characterized by increased iron absorption mediated by down-regulation of hepcidin and up-regulation of ferroportin. Blood. 2007;109(11):5027–5035.
   PubMed Web of Science ®Google Scholar
• Mishra AK, Tiwari A. Iron overload in β thalassaemia major and intermedia patients. Maedica. 2013;8(4):328–332.
   PubMedGoogle Scholar
• Cunningham MJ, Macklin EA, Neufeld EJ, et al. Complications of β-thalassemia major in North America. Blood. 2004;104(1):34–39.
   PubMed Web of Science ®Google Scholar
• Choudhry VP, Pati HP, Saxena A, et al. Deferiprone, efficacy and safety. Indian J Pediatr. 2004;71(3):213–216.
   PubMedGoogle Scholar
• De Sanctis V, Kattamis C, Canatan D, et al. β-Thalassemia distribution in the Old World: an ancient disease seen from a historical standpoint. Mediterr J Hematol Infect Dis. 2017;9(1):e2017018.
   PubMed Web of Science ®Google Scholar
• Haj Khelil A, Denden S, Leban N, et al. Hemoglobinopathies in North Africa: a review. Hemoglobin. 2010;34(1):1–23.
   PubMed Web of Science ®Google Scholar
• Chatterjee T, Chakravarty A, Chakravarty S, et al. Mutation spectrum of β-thalassemia and other hemoglobinopathies in Chittagong, Southeast Bangladesh. Hemoglobin. 2015;39(6):389–392.
   PubMed Web of Science ®Google Scholar
• Ibn Ayub M, Moosa MM, Sarwardi G, et al. Mutation analysis of the HBB gene in selected Bangladeshi β-thalassemic individuals: presence of rare mutations. Genet Test Mol Biomarkers. 2010;14(3):299–302.
   PubMed Web of Science ®Google Scholar
• Sultana GNN, Begum R, Akhter H, et al. The complete spectrum of beta (β) thalassemia mutations in Bangladeshi population. Austin Biomark Diagn. 2016;3(1):1024–1021.
   Google Scholar
• Ansari S, Shamsi TS, Ashraf M, et al. Molecular epidemiology of β-thalassemia in Pakistan: far reaching implications. Indian J Hum Genet. 2012;18(2):193–197.
   PubMedGoogle Scholar
• Sadiya S, Khan WA, Banu B, et al. Carrier detection of thalassaemia and haemoglobinopathies in tribal population of Bangladesh. Bangladesh Med Res Counc Bull. 2018;44(2):89–92.
   Google Scholar
• Qanungo SB. A history of Chittagong. Chittagong (Bangladesh): Dipanker Qanungo, Distributed by Signet Library; 1988.
   Google Scholar
• Chowdhury AM. Dynastic history of Bengal. Dacca (Bangladesh): The Asiatic Society of Pakistan; 1967.
   Google Scholar
• Karim A. Social history of the Muslims in Bengal. Dacca (Bangladesh): The Asiatic Society of Pakistan; 1959.
   Google Scholar
• Ali MM. History of the Muslims of Bengal-Muslim rule in Bengal (600-1170/1203-1757). 1st ed. Riyadh (Saudi Arabia): Imam Muhammad Ibn Sa’ūd Islamic University; 1985.
   Google Scholar
• Khan M-DA. The Arabs [Internet]. In: Islam S, editor. Banglapedia, national encyclopedia of Bangladesh. Dhaka (Bangladesh): The Asiatic Society of Bangladesh; 2014 [accessed 2022 Sept 3]. Available from: https://en.banglapedia.org/index.php?title=Arabs,_The
   Google Scholar
• Anwar S, Taslem Mourosi J, Arafat Y, et al. Genetic and reproductive consequences of consanguineous marriage in Bangladesh. PLoS One. 2020;15(11):e0241610.
   PubMed Web of Science ®Google Scholar
• Agarwal S, Wei L, Hattori Y, et al. Codon 4 ACT–>ACA, codon 5 CCT–>TCT, and codon 6 GAG–>TAG mutations in cis-position: a form of thalassemia trait. Am J Hematol. 1997;56(3):187–188.
   PubMed Web of Science ®Google Scholar
• Chakrabarti P, Gupta R, Mishra A, et al. Spectrum of β-thalassemia mutations in North Indian states: a β-thalassemia trait with two mutations in cis. Clin Biochem. 2005;38(6):576–578.
   PubMed Web of Science ®Google Scholar
• Yasmeen H, Toma S, Killeen N, et al. The molecular characterization of β globin gene in thalassemia patients reveals rare and a novel mutations in Pakistani population. Eur J Med Genet. 2016;59(8):355–362.
   PubMed Web of Science ®Google Scholar
• Singh SP, Gupta S. Molecular pathogenesis and clinical variability of homozygous β 0-thalassemia in populations of Jammu region of J&K state (India). Hematology. 2006;11(4):271–275.
   PubMed Web of Science ®Google Scholar
• Nadkarni A, Gorakshakar AC, Lu CY, et al. Molecular pathogenesis and clinical variability of β-thalassemia syndromes among Indians. Am J Hematol. 2001;68(2):75–80.
   PubMed Web of Science ®Google Scholar